Frozen shoulder (adhesive capsulitis) affects an estimated 2–5% of the general population and disproportionately impacts adults between 40–65 years of age, with diabetic individuals facing a 10–36% lifetime risk — roughly 5-fold higher than the general population (Zreik et al., 2016, Shoulder and Elbow). The condition's hallmark is a fibrotic contracture of the glenohumeral joint capsule that progresses through three distinct biological phases — freezing, frozen, and thawing — each requiring a different rehabilitation approach.
The key insight that shapes effective management is that frozen shoulder is not a static condition. Its biological substrate shifts from acute synovial inflammation in Phase 1, to progressive capsular fibrosis in Phase 2, to gradual fibrolytic remodeling in Phase 3. A well-designed rehabilitation program — including near-infrared (NIR) LED photobiomodulation as a complementary wellness tool — must track these phase transitions rather than applying the same protocol throughout the natural history of the condition.
What Is Frozen Shoulder (Adhesive Capsulitis)?
What Is Frozen Shoulder (Adhesive Capsulitis)?
Frozen shoulder is defined by painful restriction of both active and passive glenohumeral range of motion (ROM), particularly in external rotation, abduction, and internal rotation. The term "adhesive capsulitis" describes the pathological substrate: synovial inflammation followed by progressive collagen cross-linking and adhesion formation in the glenohumeral joint capsule, reducing its volume from a normal 28–35 mL to as little as 5–6 mL in advanced stages (Neviaser, 1945).
Histological studies identify two key cellular populations driving the fibrosis: myofibroblasts (expressing alpha-smooth muscle actin) that generate contractile tension in the capsule, and fibroblasts activated by transforming growth factor-beta 1 (TGF-β1) that lay down excess type I and type III collagen. Elevated levels of matrix metalloproteinase inhibitors (TIMPs) prevent adequate collagen degradation, locking the capsule in a contracted state.
Risk factors beyond diabetes include thyroid disease, Dupuytren contracture, cardiac surgery, prolonged immobilization, and ipsilateral shoulder trauma. The condition is bilateral in approximately 17% of cases over a lifetime.
The Three Phases Explained: Biology and Progression
The Three Phases Explained: Biology and Progression
| Phase | Duration | Dominant Pathology | Key Symptom | Primary Goal |
|---|---|---|---|---|
| Phase 1: Freezing | 2–9 months | Synovial hypervascularization, inflammatory cell infiltration, early fibroblast activation | Progressive pain, painful arc, night pain | Pain comfort, reduce inflammation stimulus, maintain available ROM |
| Phase 2: Frozen | 4–12 months | Dense capsular fibrosis, myofibroblast contraction, capsular adhesions | Severe ROM restriction, reduced but stable pain | Slow capsular remodeling, maintain muscle function, prevent compensatory patterns |
| Phase 3: Thawing | 5–26 months | Fibrolytic remodeling, gradual MMP-mediated collagen degradation | Gradual ROM return, minimal pain | Progressive ROM and strength recovery, functional restoration |
Total natural history is typically 18 months to 3 years, though up to 40% of patients retain some functional limitation at long-term follow-up if rehabilitation is not consistently undertaken (Hand et al., 2008, JBJS). Early identification of phase transition — typically indicated by a shift from dominant pain to dominant stiffness — is critical for adapting the rehabilitation approach.
How NIR Light May Support Each Phase
How NIR Light May Support Each Phase
Near-infrared photobiomodulation at 660–850 nm interacts with tissue at a cellular level through several mechanisms relevant to each phase of frozen shoulder:
- Cytochrome c oxidase activation: 660 nm and 850 nm photons are absorbed by Complex IV of the mitochondrial electron transport chain, transiently increasing ATP production. Enhanced cellular energy availability supports synovial cell function and may reduce the metabolic stress driving inflammatory signaling in Phase 1.
- Nitric oxide release: Photo-dissociation of NO from cytochrome c oxidase causes vasodilation in local capillaries, potentially improving microcirculation in the inflamed synovium and pericapsular tissues — relevant in Phase 1 when vascular density is elevated and tissue oxygenation may be irregular.
- Fibroblast modulation: Multiple in vitro and animal studies demonstrate that NIR light modulates fibroblast proliferation and collagen synthesis rate, with effects dependent on dose (fluence). At low-to-moderate fluences (3–10 J/cm²), NIR has been associated with more regulated collagen deposition — potentially relevant in Phase 2 where uncontrolled fibroblast activity drives pathological capsular contraction.
- Anti-inflammatory signaling: NIR light inhibits NF-κB activation and reduces prostaglandin E2 production in activated macrophages — two pathways central to the synovial inflammatory cascade in Phase 1 (de Freitas & Hamblin, 2016, Photomedicine and Laser Surgery).
It is important to frame these mechanisms appropriately: the CIRIUS NIR LED device is a healthcare/wellness device, not a medical treatment. These cellular-level mechanisms suggest plausible pathways through which NIR light may support the body's natural recovery processes in each phase — they are not claims of treating or curing adhesive capsulitis.
Phase 1 (Freezing): Pain Management and Circulation Support
Phase 1 (Freezing): Pain Management and Circulation Support
During the freezing phase, the dominant clinical challenge is pain management while preventing further ROM loss. Exercise during this phase should be gentle and focus on maintaining — not gaining — range of motion. Aggressive stretching during active synovial inflammation may worsen the condition by increasing inflammatory mediators.
NIR Application for Phase 1
- Wavelength priority: 660 nm (penetrates to approximately 2–3 cm, targeting the inflamed synovium and superficial capsule)
- Fluence: 4–6 J/cm² per point (lower end to avoid biphasic dose-response suppression in inflamed tissue)
- Duration: 8–12 minutes per session, targeting the anterior, posterior, and superior capsule zones
- Frequency: Once daily, ideally 30–60 minutes before planned mobility exercises to maximize comfort during movement
- Key precaution: Avoid direct irradiation of inflamed areas immediately after activity that has acutely exacerbated pain. Allow pain to settle first.
Prioritize sleep positioning to avoid lying directly on the affected shoulder, which compresses the inflamed capsule and disrupts sleep — a significant quality-of-life issue in Phase 1.
Phase 2 (Frozen): Mobility Work and Tissue Remodeling Support
Phase 2 (Frozen): Mobility Work and Tissue Remodeling Support
In the frozen phase, the dominant impairment shifts to stiffness. Pain is still present but usually less severe and more localized to end-range positions. This phase represents the most challenging period for patient motivation, as the spontaneous thawing process has not yet begun and functional restriction is maximal.
NIR Application for Phase 2
- Wavelength priority: 850 nm (penetrates to approximately 4–5 cm, reaching the joint capsule and rotator cuff muscle-tendon junctions)
- Fluence: 8–12 J/cm² per point
- Duration: 12–15 minutes per session
- Frequency: Once daily, applied 20–30 minutes before stretching/mobilization exercises to promote tissue warmth, improved local circulation, and reduced stiffness sensation
- Application zones: Anterior capsule (coracohumeral ligament region), posterior capsule, axillary recess (apply from the lateral shoulder with arm supported in slight abduction)
The goal of pre-stretch NIR application in Phase 2 is to create a tissue environment where mobilization is more comfortable — not to replace manual therapy or professional physiotherapy, but to complement it at home between supervised sessions.
Phase 3 (Thawing): Progressive Loading and ROM Recovery
Phase 3 (Thawing): Progressive Loading and ROM Recovery
The thawing phase is characterized by gradual spontaneous ROM recovery as fibrolytic enzymes begin degrading the pathological collagen crosslinks. Progress is slow — typically 1–3° ROM gain per week — but measurable. This is the most psychologically rewarding phase and the one where consistent rehabilitation work has the highest return.
NIR Application for Phase 3
- Wavelength: Combined 660+850 nm for comprehensive superficial and deep tissue coverage
- Fluence: 8–12 J/cm² per point
- Duration: 10–15 minutes per session
- Frequency: 5–7 times per week — both pre-exercise (15–20 min before stretching) and post-exercise (for recovery comfort after progressive loading sessions)
As ROM improves in Phase 3, it is critical to progressively introduce rotator cuff strengthening to address the muscle atrophy and neuromuscular inhibition that accumulated during Phases 1 and 2. Regaining ROM without addressing strength sets up compensatory movement patterns and potential recurrence.
Complementary Rehabilitation Exercises by Phase
Complementary Rehabilitation Exercises by Phase
The following exercises are organized by phase appropriateness. Always work within a pain range of 3–4/10 or below during the freezing and early frozen phases. Mild stretching discomfort at end-range (not sharp pain) is acceptable in late frozen and thawing phases.
Phase 1 Exercises (Maintain ROM, Avoid Exacerbation)
- Pendulum circles: Lean forward, let arm hang freely, make small clockwise and counter-clockwise circles using trunk momentum — not shoulder muscle activation. 30 seconds × 2–3 sets, 2× daily
- Supine external rotation with cane: Lying on back, use unaffected arm to assist gentle external rotation. Hold 10–20 seconds. Keep movement within comfort range.
- Table slides: Seated, slide affected arm forward on smooth table surface, using body lean to passively lengthen anterior structures
Phase 2 Exercises (Increase ROM, Address Adhesions)
- Doorway stretch: Stand in doorway at 90° elevation, gently lean forward to stretch anterior capsule. Hold 30–45 seconds × 3 sets after NIR application
- Cross-body stretch: Bring affected arm across body, use unaffected hand at elbow to gently increase horizontal adduction — targets posterior capsule
- Sleeper stretch: Side-lying on affected shoulder, gently push forearm downward to stretch posterior capsule in internal rotation. Hold 30–60 sec
Phase 3 Exercises (Restore Strength and Function)
- Resisted external rotation with band: Elbow at side, 90° flexion, rotate outward against resistance band. 3 × 15 reps
- Prone Y-T-W: Lying face-down, perform scapular retraction + arm lifts in Y, T, and W positions. Activates lower and middle trapezius
- Full ROM overhead reach progression: Start supine with arms supported, progress to standing overhead reach as pain allows
When to Seek Professional Evaluation
When to Seek Professional Evaluation
Frozen shoulder is a self-limiting condition in most cases, but professional evaluation is important and recommended in the following situations:
- Pain that is severe, constant (not related to movement), or accompanied by fever, swelling, or redness — may indicate infection or other pathology requiring urgent evaluation
- Rapid onset of complete ROM loss within days (rather than the typical gradual progression over weeks to months) — could indicate locked dislocation or other acute joint pathology
- Suspected fracture following trauma
- Failure to progress through Phase 2 after 6 months of consistent rehabilitation
- Neurological symptoms (numbness, tingling, weakness beyond shoulder) — suggests nerve involvement not typical of frozen shoulder
- Presence of concurrent diabetes, thyroid disease, or prior cardiac surgery — warrants closer monitoring given elevated risk of prolonged course
A physiotherapist experienced in shoulder rehabilitation can guide phase-appropriate exercise intensity, apply manual therapy (joint mobilizations, which have stronger evidence than stretching alone for improving ROM in Phase 2), and determine when corticosteroid injection or hydrodilation might be appropriate adjuncts to conservative rehabilitation.


